Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

von Willebrand disease

W C Nichols1, D Ginsburg

  • 1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA.

Medicine
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Molecular defects in von Willebrand disease (VWD) are increasingly understood, aiding diagnosis. Type 1 VWD remains challenging, but DNA diagnostics and prenatal testing offer future improvements for this bleeding disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissection Wounds.

Atlanta medical and surgical journal·2022
Same author

Inguinal Aneurism Cured by Digital Compression.

Atlanta medical and surgical journal·2022
Same author

DOSE DEPENDENCE OF RADIATION INDUCED DAMAGE IN THE THERMOLUMINESCENT RESPONSE OF LIF:Mg,Ti (TLD-100).

Radiation protection dosimetry·2020
Same author

Alpha galactosidase A activity in Parkinson's disease.

Neurobiology of disease·2018
Same author

Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.

Journal of thrombosis and haemostasis : JTH·2016
Same author

The molecular biology of von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2013

Area of Science:

  • Hematology
  • Molecular Genetics
  • Human Genetics

Background:

  • Von Willebrand disease (VWD) is a heterogeneous bleeding disorder with diverse molecular underpinnings.
  • Significant advancements have been made in identifying specific molecular defects for several VWD types.

Purpose of the Study:

  • To review the progress in characterizing molecular defects in VWD.
  • To highlight challenges in diagnosing common VWD types and the need for improved diagnostics.
  • To discuss the implications of molecular insights for VWF structure, function, and therapeutic strategies.

Main Methods:

  • Review of molecular genetic studies in VWD.
  • Analysis of diagnostic challenges and advancements.
  • Discussion of structure-function relationships of the von Willebrand factor (VWF).

Related Experiment Videos

Main Results:

  • Precise molecular characterization is achievable for VWD types 2A, 2B, 2N, and 3.
  • Type 1 VWD, the most common variant, remains a diagnostic challenge.
  • DNA-based diagnostics and prenatal testing are becoming increasingly feasible for VWD.

Conclusions:

  • Continued molecular characterization of VWD improves understanding of pathogenesis and facilitates precise diagnosis.
  • Development of DNA-based diagnostics is crucial due to limitations in current clinical laboratory tests.
  • Insights into VWF molecular basis may lead to novel therapeutic approaches for bleeding and thrombotic disorders.